COLL
the council passes — AVOIDCOLLEGIUM PHARMACEUTICAL, INC·Healthcare
Doesn't clear the council's bar right now.
64/100C
Price at last run$36.06as of Jul 8, 2026
healthcareHigh returns on capitalROIC ~168% — it earns well on the money it puts to work.
Fat operating margins23% operating margin — pricing power / a real moat hint.
Generates real cash28.6% free-cash-flow yield — profits you can actually bank.
GrowingRevenue growing ~24%.
Clean balance sheetLow leverage (debt/equity 0.00).
Catalystnone yet
✕Why not
The honest case against — what most tools hideWhat keeps us out
- A deterioration in the fundamentals that score the business.
Patience price & distance
as of Jul 8, 2026 runThe patience price is where value discipline would let the council in — deliberately strict: we'd rather miss ten winners than own one loser.
Catalyst
none yet
A catalyst is a plausible reason the gap could close — never a certainty.